ARCHIVES

Cancer Groups Endorse Pazdur For FDA Commissioner.

This article is from The Cancer Letter archive.

Vol. 27 No. 03 | January 19, 2001

Download PDF Visit The Full Archive

Related Articles

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

First Report On Carcinogens Now Avaiable

October 3, 1980

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

Mail Mixup Delays July 23 Issue

August 6, 1976